Portfolio Companies 2026 for Deep Track Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Deep Track Capital accounts for 19 tracked companies with verified cap-table data, 19 of which disclose round sizes totalling $3.9B. The median disclosed raise is $144M, and the largest is Spyre Therapeutics at $644M, ahead of TORL BioTherapeutics ($450M) and Avenzo Therapeutics ($446M).
The names that recur most often on these portfolio cap tables are Deep Track Capital (19 companies), RA Capital Management (6 companies), OrbiMed (5 companies), Frazier Life Sciences (4 companies), Surveyor Capital (4 companies), Janus Henderson Investors (4 companies). By latest disclosed round, the market skews Series C (7), Series B (6), Series A (3), Growth (1).
Companies tracked: 19
Disclosed funding total: $3.9B across 19 companies
Median disclosed raise: $144M
Largest raise: Spyre Therapeutics — $644M
Stage mix: Series C 7 · Series B 6 · Series A 3 · Growth 1
